益赛普治疗难治性银屑病一例
摘要
1病历资料
1．1病史：忠者男性，47岁，皮疹30年，四肢关节肿痛6年加重1个月余，发热3天入院。
出处
《中国美容医学》
CAS
2012年第10X期622-622,共1页
Chinese Journal of Aesthetic Medicine
二级参考文献17
-
1HUTMACHER M M, NESTOROV I, LUDDEN T, et al. Modeling the exposure - response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis[ J]. J Clin Pharmacol, 2007, 47(2) :238 -248.
-
2KORTH-BRADLEY J M, RUBIN A S, HANNA RK, et al. The pharmacokinetics of etanercept in healthy volunteers [ J ]. Ann Pharmacother, 2000, 34(2) : 161 - 164.
-
3NESTOROV I, ZITNIK R, DE VRIES T, et al. Pharmacoklnetics of subcutaneously administed etanercept in subjects with psoriasis [J]. Br Clin J Pharmacol, 2006, 62(4) : 435 - 445.
-
4WONG V K, LEBWOHL M G. Treatment of psoriasis arthritis with etanereept, a tumour necrosis factor angagonist [ J ]. Expert Opin Biol Ther, 2005,5(11) :1505 - 1513.
-
5GOFFE B. Etanercept(Enbrel)--an update [ J ]. Skin Therpy Lett, 2004 Dec - 2005Jan, 9(10) :1 -4.
-
6MALAVIYA R, SUN Y, TAN J K, et al. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients[J]. J Am Acad Dermatol, 2006,55(4):590-597.
-
7WOOLACOTT N, HAWKINS N, MASON A, et al. Etanereept and efalizubab for the treatment of psoriasis: a systemic review [ J ]. Health Technology Assessment, 2006, 10(46) :1 -252.
-
8ESPOSITO M, MAZZOTTA A, DE FELIICE C, et al. Treatment of erythrodermic psoriasis with etanercept [ J ]. Br J Dermatol, 2006,155 ( 1 ) : 156 - 159.
-
9ELEWSKI B, LEONARDI C, GOTTIEB A B, et al. Comparison of clinical and pharmacokinetic profile of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis [ J ]. Br J Dermatol, 2007,156( 1 ) : 138 - 142.
-
10LEONARDI C L, POWER J L, MATHESON R T, et al. Etanercept as monothempy in patients with psoriasis[J]. N Engl J Med, 2003, 349(21):2014-2022.
共引文献5
-
1何秋波,尹光文,李红文,董慧婷.益赛普治疗泛发性脓疱型银屑病20例[J].郑州大学学报（医学版）,2010,45(4):668-670. 被引量：4
-
2左雅敏.益赛普联合柳氮磺吡啶治疗80例类风湿性关节炎的临床研究[J].现代预防医学,2011,38(13):2646-2647. 被引量：11
-
3贺芬,李敦国,陈明亮,姚晓长.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合银屑颗粒治疗中、重度寻常型银屑病的疗效观察[J].中国药房,2013,24(24):2245-2247. 被引量：1
-
4何瑶玉,张娟,王旻.单抗及Fc融合蛋白治疗自身免疫性疾病的现状及比较分析[J].中国新药杂志,2014,23(3):278-281. 被引量：2
-
5张英虎.益赛普联合甲氨蝶呤治疗中重度银屑病疗效观察[J].世界最新医学信息文摘,2015,0(56):76-76.
-
1何弘,张晖,姚岚,徐晓迪.NB-UVB治疗银屑病致红皮病1例[J].中国麻风皮肤病杂志,2007,23(8):645-645.
-
2何秋波,尹光文,李红文,董慧婷.益赛普治疗泛发性脓疱型银屑病20例[J].郑州大学学报（医学版）,2010,45(4):668-670. 被引量：4
-
3成志明.关节病性银屑病伴自发性气胸一例[J].中华皮肤科杂志,2003,36(3):171-171.
-
4王丹,李顺凡,吴志华.环孢素A治疗难治性银屑病的临床体会[J].广东医学院学报,1998,16(4):359-360. 被引量：2
-
5徐丽敏.益赛普治疗寻常性银屑病[J].中华皮肤科杂志,2012,45(1):74-74.
-
6丁杨峰,易雪梅,楼玮,陆家睛.钙泊三醇倍他米松软膏治疗难治性银屑病的临床疗效和安全性观察[J].中国中西医结合皮肤性病学杂志,2015,14(1):35-36. 被引量：7
-
7牛铁荣.中医辨证治疗银屑病72例临床观察[J].中国民间疗法,2016,24(4):48-49. 被引量：1
-
8刘丹,徐丽华,牛慧卿.阿维A联合甲氨蝶呤治疗泛发性脓疱型银屑病的疗效及安全性[J].医药论坛杂志,2016,37(9):147-148. 被引量：4
-
9严繁淦,王桂月,葛昊平.益赛普与甲氨蝶呤治疗关节型银屑病疗效比较[J].中国实用乡村医生杂志,2012,19(19):50-51. 被引量：2
-
10樊平申,李腾蛟,廖文俊,高天文,胡雪慧.环孢素治疗难治性银屑病1例[J].临床皮肤科杂志,2005,34(3):193-193. 被引量：1
